For instance, a team-based care management program for 214 patients with diabetes, heart disease and comorbid depression was associated with a more frequent and timely treatment adjustment for antidepressants, insulin and antihypertensive medications by physicians and more frequent patients’ self-monitoring blood pressure and glucose, leading to improved control of diabetes, depression, and heart disease [45]. This evidence concerns the gene INS and major depressive disorder.